Thomas Charles Reilly serves as Executive at Cara Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Thomas Charles Reilly has executed 16 insider transactions totaling $51.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 20, 2024 involved exercising options for 33,333 shares valued at $0.
Thomas Charles Reilly currently holds 102,264 shares of Cara Therapeutics, Inc. (CARA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Charles Reilly has been a net seller of CARA stock. They have purchased $0 and sold $51.4K worth of shares.
Thomas Charles Reilly's most recent insider trade was on Jun 20, 2024, when they sold 33,333 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 16,417 |
| $0.73 |
| Discretionary |
| Jan 31, 2024 | AMRN | $0 | Option Exercise | 44,933 | $N/A | Discretionary |
| Jan 31, 2024 | AMRN | $30.4K | Payment | 24,552 | $1.24 | Discretionary |
| Jan 10, 2024 | AMRN | $27.5K | Payment | 28,325 | $0.97 | Discretionary |
| Jan 10, 2024 | AMRN | $0 | Option Exercise | 51,500 | $N/A | Discretionary |
| Jul 1, 2023 | AMRN | $9.8K | Payment | 8,209 | $1.19 | Discretionary |
| Jul 1, 2023 | AMRN | $0 | Option Exercise | 16,667 | $N/A | Discretionary |
| Jun 20, 2023 | AMRN | $0 | Option Exercise | 33,334 | $N/A | Discretionary |
| Jun 20, 2023 | AMRN | $19.5K | Payment | 16,417 | $1.19 | Discretionary |
| Mar 3, 2022 | CARA | $23.3K | Sale | 2,044 | $11.38 | Discretionary |
| Feb 28, 2022 | CARA | $54.9K | Award | 5,333 | $10.29 | Discretionary |
| Feb 25, 2022 | CARA | $0 | Award | 20,000 | $N/A | Discretionary |
| Dec 17, 2021 | CARA | $0 | Award | 11,170 | $N/A | Discretionary |
| Aug 30, 2021 | CARA | $28.1K | Sale | 1,982 | $14.20 | Discretionary |
| Aug 24, 2021 | CARA | $0 | Award | 5,334 | $N/A | Discretionary |